INTRODUCTION
The targeting of soluble lysosomal enzymes, such as cathepsin D (EC 3.4.23.5) , to lysosomes is mediated by mannose 6-phosphate residues and specific receptors (Kornfeld, 1992) . Several observations indicate that in mammalian cells other, as yet unknown mechanisms, participate in the transport of the soluble enzymes to lysosomes (von Figura and Hasilik, 1986) . In Saccharomyces cerevisiae, protein structure signals are responsible for the targeting of proteinases to the vacuole (Paravicini et al., 1992) . In human cells, lysozyme (EC 3.2.1.17) may be a candidate for carbohydrate-independent lysosomal targeting. During the 70 years of research since its discovery (Fleming, 1922) , lysozyme has become one of the most studied proteins (Jolles and Jolles, 1984; McKenzie and White, 1991) . Nevertheless, little is known about its biological actions or its intracellular transport. Lysozyme is considered to be a secretory product of various epithelial cells and leucocytes. However, it is also present in leucocytes where it is associated with secretory granules and lysosome-like organelles (Baggiolini et al., 1969; Miyauchi et al., 1985; Cramer and Breton-Gorius, 1987; Mapp and Revell, 1987; Ohtani and Sasano, 1988; Mutasa, 1989) . Ralph et al. (1976) have reported that, in the human promonocytic cell line U937, approx. two-thirds ofthe activity oflysozyme is found in the medium and the remainder in the cells. In our previous work reporting on a subcellular fractionation of U937 cells, lysozyme had been found in the same fractions as typical lysosomal marker enzymes (Gupta et al., 1985) . We have used 1,25-dihydroxycholecalciferol (calcitriol)-treated U937 cells, in which the detection of both cathepsin D and lysozyme is facilitated owing to an enhanced rate of transcription (Redecker et al., 1989) . We present immunocytochemical evidence that lysozyme and cathepsin D localize to the same organelles and, further, results on metabolic labelling which show that the transport ofthese two enzymes to lysosomes is distinctly inhibited the lysosomal targeting of procathepsin D by NH4C1 and 4/3-PMA is additive. The targeting of lysozyme is partially inhibited in the presence of R-59022, an inhibitor of diacylglycerol kinase, whereas it is not affected by 4a-phorbol 12-myristate 13-acetate, an isomer of 4,8-PMA that does not activate protein kinase C. It is concluded that in U937 cells both carbohydrate-dependent and -independent recognition contributes to the lysosomal targeting of soluble proteins. We suggest that the carbohydrateindependent traffic of proteins to lysosomal compartments is controlled by a signalling pathway involving protein kinase C.
in the presence of agents known to affect the acidification of intracellular compartments or the activity of protein kinase C.
MATERIALS AND METHODS Cells, culturing and metabolic labelling
Human promonocytic U937 cells were cultured in RPMI 1640 medium (Gibco BRL, Eggenstein, Germany) that was supplemented with 10% (v/v) heat-inactivated fetal-calf serum (bio pro, Karlsruhe), 100 units/ml penicillin and 100 ug/ml streptomycin under air/CO2 (19: 1, v/v). All experiments were performed with cells which were cultured (starting at a density of 1.5 x 105 cells/ml) in the presence of 0.5 ,M calcitriol for 3 days. Calcitriol was donated by Dr. M. R. Uskokovic (Hoffmann La Roche, Nutley, NJ, U.S.A.). 4#-Phorbol 12-myristate 13-acetate (4,6-PMA; 'TPA') was from Sigma Chemie (Deisenhofen, Germany) and R-59022 from Janssen Biochimica (Olen, Belgium). 4a-Phorbol 12-myristate 13-acetate (4a-PMA) was from Biomol (Hamburg, Germany). Metabolic labelling was performed in the above medium, lacking methionine or methionine and cysteine, in the presence of 0.4-2 MBq/ml of [35S]methionine (specific radioactivity 40 TBq/mmol, from Amersham-Buchler, Braunschweig, Germany) or Tran35S-label (specific radioactivity 40 TBq/mmol, from ICN Biomedicals).
Immunoprecipitatlon and separation of the labelled proteins
The preparation ofextracts of cell and growth medium, immunoprecipitation with affinity-purified antibodies and purified goat anti-(rabbit IgG) antibody-coated Eupergit C1Z (Rohm Pharma, Weiterstadt, Germany), washing and solubilization of the immunoprecipitates were all performed as described previously (Grassel et al., 1989) . The labelled proteins were separated in SDS/PAGE (Laemmli, 1970 (Laskey and Mills, 1975) and, in selected experiments, it was quantified by scintillation counting (Waheed et al., 1982) and densitometry using a laser densitometer (Ultroscan model from Pharmacia).
Enzyme assays
The activity of ,J-hexosaminidase and /8-glucuronidase was determined with the corresponding p-nitrophenyl glycoside substrates. The samples were filled up to 50,1 with 0.14 M NaCl and the assay was started by adding 50 1ld of a 10 mM substrate solution prepared in 0.2 M Na/citrate buffer (pH 4.6)/0.20% (v/v) Triton X-100/0.04 % (w/v) NaN3/0.2 % (w/v) BSA. After an incubation at 37°C the reaction was stopped by adding 0.5 ml of 0.4 M glycine/NaOH buffer, pH 10.4. The absorbance was determined at 405 nm. One unit was calculated as 1 umol of substrate utilized/min (e 18.4 mM-1'cm-l).
Electron microscopy The cells were fixed with 2 % (w/v) paraformaldehyde in 50 mM sodium phosphate buffer, pH 7.4. Ultra-thin cryosections of 50-100 nm thickness were prepared and subjected to double labelling (Geuze et al., 1981) with affinity-purified antibodies against lysozyme and cathepsin D, and 5-and 9-nm-diam. Protein A-coated gold particles. Then, the sections were stained with uranyl acetate and embedded in methylcellulose (Geuze et al., 1981) . To estimate the area of lysosomes the profiles were treated as ovals and circles and the lengths of their axes or diameters were measured.
Statistics
The activity of /J-hexosaminidase was determined in each cell homogenate and medium sample in triplicate. Data from separate cultures are given as means + S.D. (number of cultures). Data from radioactive labelling of lysozyme were calculated as percentages of that recovered from cells and the medium in each culture. At most two cultures with the same treatment were studied in parallel. Differences between mean values were analysed by two-sided Student's t-test (level of significance P < 0.05).
RESULTS

Localization of lysozyme and cathepsin D in lysosomes
To determine the intracellular localization of lysozyme, ultrathin frozen sections of fixed U937 cells were prepared and lysozyme and cathepsin D were labelled by sequential incubations with specific antibodies and Protein A-coated gold particles of different sizes. In Figure 1 [range (10-92) x 10-'5 i2]. All of them (n = 99) contained particles of both sizes. The average scores were 19 + 11 for cathepsin D and 11 + 5 for lysozyme. The average ratio of cathepsin D to lysozyme counts was 1.98 + 1.13. Furthermore, cathepsin D and lysozyme were found in small vesicles and tubules. The vesicles contained a smaller number of particles, often of only one kind. However, the scarcity of the labelling of the tubules and vesicles precluded a statistical evaluation for these compartments. It can be concluded that lysozyme is delivered to the same organelles as cathepsin D. This is supported by previous results on subcellular fractionation of U937 cells, in which lysozyme has been found in the same fractions as cathepsin D and /3-hexosaminidase (Gupta et al., 1985) .
Lysosomal targeting of lysozyme and cathepsin D and its sensitivity to 4fp-PMA and NH4CI
In most cells in which we can detect lysozyme, such as human colon carcinoma Caco-2, hepatoma HepG2, promonocytic THP-1 cells and in baby hamster kidney cells transfected with human lysozyme cDNA (Horst et al., 1991) , more than 90 % of lysozyme is secreted. In contrast, the promonocytic U937 cells package a relatively large proportion of lysozyme into lysosomes. For the following reason we suggest that this packaging is intracellular. We have shown previously (Gupta et al., 1984 ) that U937 cells endocytose cathepsin D in a mannose 6-phosphate-sensitive manner. Now, under the same conditions, we have examined the uptake by U937 cells of cathepsin D and lysozyme from a secretion of metabolically labelled cells. At a concentration of 1 x 106 cells/ml the clearance rate of lysozyme from the medium is 1.4 ,l/mg of protein per 24 h (mean of two measurements). It is more than an order of magnitude less than the clearance rate of cathepsin D (results not shown). Under the conditions used it could account for < 0.30% of the produced lysozyme being delivered to lysosomes via secretion and endocytosis.
In a search for agents that would interfere selectively with the targeting of either lysozyme or procathepsin D we have observed that 4,-PMA at a concentration as low as 2 nM stimulates preferentially the secretion of the former. Maximum secretion is observed at 0.1-1 #M 4,/-PMA. In the experiment shown in of proteins from the Golgi apparatus is inhibited (Pelham, 1991) . After the temperature is raised to 37°C the transport ensues and its sensitivity to 4,8-PMA can be examined. In Figure 3 results of two experiments with the temperature shift are presented. During a 2-h-long labelling and a 4-h-long chase at 20 "C there is no secretion of lysozyme and procathepsin D, and also the maturation of the latter in the cells is prevented (results not shown).
In Figure 3 (a) it is shown that after warming the labelled cells to 37°C approx. half of the accumulated radioactive lysozyme is secreted. In the presence of 4,-PMA the secretion is stimulated.
It appears to take less than 20 min for half of the secretable portion of lysozyme to become released into the medium at 37 'C. This rate is compatible with that of the transport of secretory proteins from the trans-Golgi apparatus to the plasma membrane (Fries and Lindstrom, 1986 (Figure 3b, lanes 1 and  2) . After an 80 min delay there is much less secretion (lanes 9 and 10); although, a large amount of the radioactive lysozyme remains within the cells (Figure 3, lanes 11 and 12) (Figure 2 ), indicating that 4,8-PMA stimulates the secretion of the newly synthesized enzyme. It is not clear, however, whether the effect of 4,-PMA on secretion is long-lasting. On the one hand, after 18 h much less /-hexosaminidase is found in the medium than would be expected from the activity which is released after 1 h. This may be explained by a temporary nature for the stimulation and also by binding to cells and by endocytosis of the released enzyme. On the other hand, when the incubation for 18 h, with or without 4/3-PMA, is followed by that for 1 h without 4/3-PMA significantly more enzyme activity is released from those cells which have been preincubated with the drug than from those without (sample numbers 3 and 4, P < 0.01). In this case the difference may be due partly to a long-lasting effect of the drug on the secretion, but also due to release of the enzyme from a cell-surface pool that may have built up during the preincubation with 4,f-PMA. The presence of ,7-hexosaminidase at the cell surface of endothelial and other human cells has been demonstrated previously (Hasilik et al., 1981) . A qualitatively similar effect of 4/3-PMA can be observed with fl-glucuronidase, although, the basal rate of the secretion of this enzyme is lower than that of /7-hexosaminidase. After an 18 h incubation with or without 4,-PMA the medium contains 0.026 munit/ml and 0.062 munit/ml of 8-glucuronidase activity (mean of two experiments). The latter value is near to 5 % of the total activity in the culture. Other human monocytic cells such as THP-1, which show a higher basal rate of the secretion of these lysosomal glycosidases, respond similarly to the treatment with 4/7-PMA (results not shown).
Indirect evidence for a role of protein kinase C in the stimulated secretion of lysozyme In U937 cells 4,8-PMA has been shown to cause rapidly an enlargement of multivesicular bodies (Nilsson et al., 1989) . Commonly, the rapid onset effects of 4,-PMA are considered to result from an activation of one or more protein kinase C isoforms. Also, in calcitriol-treated U937 cells, protein kinase C becomes attached to membranes within a few minutes of the Table 1 Effect of 4fp-PMA on the apparent secretion of fl-hexosaminidase
The cells were incubated with (+) or without (-) 0.5 ,uM 4,J-PMA for 18 h, the medium was collected and the cells were incubated for another hour with fresh medium with or without 4,/-PMA as indicated. The activity in the medium of samples 3-6 represents the enzyme secreted during the last hour of incubation.
PMA ( addition of 4,8-PMA (Rubin et al., 1991) . To see if protein kinase C is involved in the stimulation of lysozyme secretion we have compared the effect of 4,8-PMA with that of two related drugs.
In Figure 4 , we show that in the presence of the 4a-isomer of 4,8-PMA, which is known not to stimulate protein kinase C, the secretion of lysozyme is not changed. In contrast, R-59022, an inhibitor of diacylglycerol kinase (Ederveen et al., 1990) , which has potential for indirect stimulation of protein kinase C, enhances the fractional rate ofthe secretion of lysozyme. The interpretation of these data is complicated by the fact that there is a decrease in the total radioactivity incorporated into lysozyme in the presence of R-59022. However, the total amount of lysozyme in either the LM : . , l l l l l l l m ;" " " "
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control or treated cells is not changed any further if the treated cultures are subjected to a chase incubation for up to 48 h (results not shown). This result suggests that R-59022 partially inhibits the labelling of lysozyme and, simultaneously, stimulates its secretion rather than causing a loss of the cellular enzyme. To examine the significance of the stimulation of the secretion, we have evaluated quantitatively the radioactivity associated with the intracellular and secreted lysozyme using calcitriol-treated cells that had been metabolically labelled for 18 h in the absence or presence of R-59022. For this purpose data were taken from the experiment shown in Figure 4 and from three others. The quantification was performed with six pairs of control and R-59022-treated cells. In the presence of the drug 64.2 + 1.4 % lysozyme was secreted and in the control it was only 50.8 + 7.3 % (n = 6, P < 0.01). Under the same conditions 4,-PMA enhanced the secretion to 88.3 + 3.4 % (n = 3). Hasilik, 1986; Kornfeld, 1992) , the rate of the targeting of lysozyme is little affected, whereas that of procathepsin D is suppressed to approximately the same level. Under these conditions the lysosomal targeting of procathepsin D is rather sensitive to 4/J-PMA also. The lysosomal transport of lysozyme and the acidification-independent lysosomal transport of procathepsin D may be paradigms of alternative targeting such as are postulated to operate in tissues that are little or not affected by the I-cell mutation (von Figura and Hasilik, 1986; Kornfeld, 1992) .
In the presence of 4,/-PMA the secretion of f,-hexosaminidase is also elevated. Previously, Leoni and Dean (1983) observed no enhancement of the secretion of ,-hexosaminidase in U937 cells incubated with 1 nM 4f8-PMA. However, this is a much lower concentration of the drug than used in the present work. We have examined the dose dependence of the secretion of procathepsin D and observed that for the maximum effect more than 10 nM 4,f-PMA is needed.
In the presence of NH4C1 the formation in trans-Golgi apparatus of vesicles containing mannose-6-phosphate receptors is not blocked (Braulke et al., 1987) . It is the unloading of the phosphorylated ligands from the receptor, but not the packaging or the transport of the receptor, which is inhibited. Therefore, the lack of inhibition of the lysosomal segregation of lysozyme in the presence of NH4Cl does not preclude a packaging of lysozyme into the same vesicles as cathepsin D. In this case the packaging of lysozyme into these vesicles would be selectively inhibited by 4,6-PMA. As an alternative, lysozyme may be packaged into distinct vesicles in an as yet unidentified portion of the Golgi apparatus in a 4,/-PMA-sensiitive manner. Finally, 4,6-PMA may affect a more distal event such as fusion of lysozyme-bearing vesicles with their address compartment.
The rapid onset of the stimulation of the secretion of Iysozyme with an involvement of the signalling cascade, commencing with protein kinase C. This suggestion is supported by the observation that both 4/J-PMA and R-59022, but not the 4a-isomer of 4,/-PMA, enhance the secretion of lysozyme.
It is known that 4,f-PMA affects the exocytosis of soluble proteins and the subcellular distribution of membrane proteins. For example, 4,-PMA stimulates the secretion of specific-granule contents, including lysozyme, in neutrophils (Barrowman et al., 1987) , of milk protein in epithelial cells (Turner et al., 1992) , or of noradrenaline in PC12 cells (Nishizaki et al., 1992) . Among a variety of proteins which are translocated to the plasma membrane as a result of treatment of cells with 4,-PMA there is also the mannose-6-phosphate/insulin-like growth factor II receptor (Braulke et al., 1990) . This effect has been recognized in human fibroblasts and shown not to be accompanied by a stimulation of the secretion of mannose 6-phosphate-containing ligands. To find out if this holds also for procathepsin D, we examined its secretion in human fibroblasts, which had been treated with 5 x 10-7 M 4fl-PMA. In the absence of NH4Cl the targeting was not inhibited by 4/J-PMA, but in its presence it was (A. Hasilik, unpublished work).
In reports from our and other laboratories Akin and Kinkade, 1986; Stromberg et al., 1986) it has been suggested that in promyelocytes the packaging of myeloperoxidase does not depend on the mannose 6-phosphate pathway, because it is not inhibited by NH4Cl. Our current study shows that in the presence of 4,8-PMA myeloperoxidase is released into the medium (C. Uhlander, and A. Hasilik, unpublished work). Based on our present findings we suggest that, in differentiating leucocytes, transport of enzymes into granulelike organelles and fusion of the latter with lysosomes may contribute to the lysosomal targeting.
